Mixed donor chimerism following stem cell transplantation for sickle cell disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mixed donor chimerism following stem cell transplantation for sickle cell disease
Authors
Keywords
-
Journal
CURRENT OPINION IN HEMATOLOGY
Volume 30, Issue 6, Pages 187-193
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-11
DOI
10.1097/moh.0000000000000786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
- (2023) Mary Eapen et al. JOURNAL OF CLINICAL ONCOLOGY
- Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series
- (2022) Alexander Ngwube et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods
- (2022) Jasmine Lewis et al. AMERICAN JOURNAL OF HEMATOLOGY
- CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease
- (2022) Hemalatha G. Rangarajan et al. BONE MARROW TRANSPLANTATION
- Sickle Cell Disease
- (2022) Patricia L. Kavanagh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism
- (2022) Rialnat AdeBisi Lawal et al. BLOOD
- Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)
- (2022) Adetola A. Kassim et al. BLOOD
- Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease
- (2022) Courtney D. Fitzhugh Hematology-American Society of Hematology Education Program
- Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither
- (2021) Richard J. Jones et al. BLOOD
- Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease
- (2021) Sunita Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation
- (2021) Julie Kanter et al. Blood Advances
- Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A Perspective
- (2020) Clare Zimmerman et al. Frontiers in Immunology
- Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study
- (2019) Lakshmanan Krishnamurti et al. AMERICAN JOURNAL OF HEMATOLOGY
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease
- (2019) Barbara Cappelli et al. HAEMATOLOGICA
- Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial
- (2019) Javier Bolaños-Meade et al. Lancet Haematology
- A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
- (2019) Elliott Vichinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy
- (2019) Alessandra Magnani et al. HAEMATOLOGICA
- A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
- (2018) Yutaka Niihara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
- (2017) Kenneth I. Ataga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study
- (2016) Olena O Seminog et al. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
- (2016) Russell E Ware et al. LANCET
- Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies
- (2015) Allison A. King et al. AMERICAN JOURNAL OF HEMATOLOGY
- Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial
- (2015) John T. Horan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT
- (2015) T Ruutu et al. BONE MARROW TRANSPLANTATION
- Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
- (2014) Matthew M. Hsieh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
- (2012) Naynesh R. Kamani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease
- (2012) J. Bolanos-Meade et al. BLOOD
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates
- (2012) Frédéric B Piel et al. LANCET
- Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
- (2010) M. Andreani et al. HAEMATOLOGICA
- Blood and marrow transplantation for sickle cell disease: overcoming barriers to success
- (2009) Javier Bolaños-Meade et al. CURRENT OPINION IN ONCOLOGY
- Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease
- (2008) Lakshmanan Krishnamurti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started